Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724833 | SCV000331974 | uncertain significance | not provided | 2017-06-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000362885 | SCV000725471 | likely benign | not specified | 2017-12-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001083617 | SCV000770485 | likely benign | Epidermolysis bullosa simplex 5B, with muscular dystrophy; Epidermolysis bullosa simplex, Ogna type; Epidermolysis bullosa simplex 5C, with pyloric atresia; Autosomal recessive limb-girdle muscular dystrophy type 2Q; Epidermolysis bullosa simplex with nail dystrophy | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000362885 | SCV001879981 | benign | not specified | 2021-01-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004542976 | SCV004775178 | likely benign | PLEC-related disorder | 2023-12-21 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |